Lay’s recall increased to highest level, could cause ‘death’: FDA
The oversight could result in “death,” at least for those with a milk allergy or sensitivity, says the FDA. FDA initiated the ...
The American Journal of Managed Care33m
Suzetrigine: First-in-Class Non-Opiate Pain Therapy is Approved by FDA
Suzetrigine (Journavx) is the first new drug approved to treat acute pain in over 20 years and the first to be classified as ...
Why Lendlease, Mesoblast, St Barbara, and Zip shares are pushing higher
Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium ...
Twins with rare genetic PKAN disease back in routine while dealing with regression on muscle function
After more than a year the HSHS Hospital/Prevea Clinic closures were announced, a couple of Eau Claire County boys have ...
FDA approves painkiller designed to eliminate addiction risk associated with opioids
Prescriptions have fallen sharply in the last decade and the current wave of the opioid epidemic is mainly due to illicit ...